Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
urea (1 trial)
vincristine (oncovin) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
busulfan (myleran) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
etoposide (vepesid) (2 trials)
fludarabine (fludara) (2 trials)
hemopoietic stem cell (1 trial)
melphalan (alkeran) (1 trial)
muromonab cd3 (Orthoclone OKT3) (1 trial)
thiotepa (1 trial)
tioguanine (Lanvis) (1 trial)
tresulfan (1 trial)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)
Trials (3 total)
Trial APIs (15 total)